DHMC Fellow Begins Hematology Mentorship Program
August 24, 2011
Former Dartmouth hematology/oncology fellow Brea Lipe, MD, recently completed the first leg of a year of preparation for a career in patient-oriented research, with the Clinical Research Training Institute (CRTI) http://hematology.org/Awards/CRTI/2195.aspx of the American Society of Hematology (ASH).
ASH chose Lipe and 19 other young investigators from among more than 50 who applied for the education and mentoring program. Lipe, who before her three-year fellowship at Dartmouth-Hitchcock Medical Center completed a three-year residency in internal medicine at Dartmouth, spent July 30-August 5 at an intensive workshop focusing on the foundation, methods, and applications of clinical research.
In addition to participating in lectures and small-group discussions on such topics as the definition of a research question, methods of observational epidemiology and clinical trial design, navigation of institutional committees, and job interviewing and negotiation, Lipe and her peers also attended informal presentations from leaders in clinical hematology research, who reflected on their careers and provided advice to those entering the field. They also worked with CRTI faculty on revising plans for their own proposed projects in clinical research, with the goal of customizing their career-development plan and a peer-reviewed research proposal that has been extensively refined and critiqued, but they form lifelong bonds with both mentors and colleagues.
"My selection for the ASH CRTI program really helps me to establish the resources and connections that I will need to pursue a clinical research career," says Lipe, now an assistant professor at the University of Kansas Medical Center. "It is an amazing opportunity. The hematology/oncology fellowship at DHMC allowed me the flexibility to explore different opportunities and and develop individual interests that could be enhanced through the help of the CRTI program."
Lipe credits the guidance of pathologist Deborah Ornstein, MD, medical director of DHMC's Comprehensive Hemophilia and Thrombosis Center, and of hematologist/oncologist Christopher Lowrey, MD, with encouraging Lipe to "develop a focused research question that allowed me to participate in the CRTI program."
Next up for Lipe and her CRTI colleagues are mentoring sessions at the ASH annual meeting in December, and in May 2012 at ASH headquarters in Washington, DC.
"When ASH started this program nine years ago, the goal was to train the next generation of clinical scientists," says ASH President J. Evan Sadler, MD, PhD, of Washington University School of Medicine in St. Louis. "Over the years, a number of participants have described the program as one of the greatest career opportunities they have experienced, and many have gone on to be successful in obtaining career-development awards and operating grants to continue their work. We are excited about this new CRTI class and their potential to do great things in hematology."
Joining Lipe in the CRTI's class of 2011 are investigators from around the United States, Canada and Australia. Hematologists and hematologists/oncologists who are in their second year of fellowship through their third year post-fellowship at academic medical centers in the United States and Canada are eligible for the ASH CRTI.
"In the future," Lipe concludes, "I hope to develop a focused clinical career in multiple myeloma and coagulopathies."